Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy

Immunity(2025)10.1016/j.immuni.2025.05.001Source: DataRank Database

Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy is a research paper published in Immunity (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 5.18)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Sebastían Fernández,Timothy Campbell ORCID,David Ventura ORCID,Jacob T. Williams,Julia Ybarra

Live enrichment

PubMed:40480220 PMC:PMC12893775 OpenAlex:https://openalex.org/W4411058130

National Cancer Institute Center for Strategic Scientific Initiatives

Grant: 1DP2CA247830-01

NIAID NIH HHS

Grant: P01 AI063302

NCI NIH HHS

Grant: DP2 CA247830

NIAID NIH HHS

Grant: R01 AI027655

NCI NIH HHS

Grant: R01 CA283604

NIGMS NIH HHS

Grant: T34 GM145535

Cancer Research Coordinating Committee

National Institutes of Health

Canada Research Coordinating Committee

FWCI

5.18

Citation Percentile

1.0%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12893775/

publisherhttps://api.elsevier.com/content/article/PII:S1074761325001943?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1074761325001943?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.immuni.2025.05.001

Fields of Study

Cancer Research and TreatmentsNanoplatforms for cancer theranosticsImmunotherapy and Immune ResponsesMedicineBiologyAnimalsListeria monocytogenesMiceCD8-Positive T-LymphocytesImmunotherapyMice, Inbred C57BLAntigens, NeoplasmCancer VaccinesApoptosisCell Line, TumorNeoplasmsNeutrophilsFemaleCross-PrimingHumans

MeSH Terms

AnimalsAntigens, NeoplasmFemaleHumansImmunotherapyListeria monocytogenesMice, Inbred C57BLNeoplasmsNeutrophilsApoptosisCD8-Positive T-LymphocytesCancer VaccinesCross-PrimingCell Line, TumorMice

Keywords

BiologyImmunotherapyCancer researchImmunologyImmune systemInfectious diseasetumor immunologyadaptive immunityImmunotherapiesBacterial Immunotherapy

Sustainable Development Goals

SDG 0: Zero hunger

Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy

FAIR Checklist

Authors (10)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)